NCT06058936

Brief Summary

in this study, a randomized controlled trial will be conducted to evaluate the effect of adding exercises using virtual reality on achievements in patients having breast cancer and conducted surgical treatment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2023

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 21, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 28, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

January 7, 2025

Status Verified

November 1, 2023

Enrollment Period

9 months

First QC Date

September 21, 2023

Last Update Submit

January 5, 2025

Conditions

Outcome Measures

Primary Outcomes (12)

  • Handgrip strength

    will be measured by Pablo system for the affected and unaffected upper limbs

    at baseline

  • handgrip strength

    will be measured by Pablo system for the affected and unaffected upper limbs

    after the end of the treatment (after 8 weeks)

  • wrist joint active range of motion (ROM)

    flexion and extension active ROM of the wrist joints will be assessed using Pablo system

    baseline

  • wrist joint active ROM

    flexion and extension active ROM of the wrist joints will be assessed using Pablo system

    after the end of the treatment (after 8 weeks)

  • Disabilities of the Arm, Shoulder and Hand (DASH)

    DASH is a 30-item questionnaire. Each item is scored on a 1 (no difficulty) to 5 (unable) scale. The total score may range from 0 to 100 points. High scores indicate a high level of disability.

    at baseline

  • Disabilities of the Arm, Shoulder and Hand (DASH)

    DASH is a 30-item questionnaire. Each item is scored on a 1 (no difficulty) to 5 (unable) scale. The total score may range from 0 to 100 points. High scores indicate a high level of disability.

    after the end of the treatment (after 8 weeks)

  • Fatigue by Multidimensional Fatigue Inventory

    The MFI is a 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue.

    at baseline

  • Fatigue by Multidimensional Fatigue Inventory

    The MFI is a 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: general fatigue, physical fatigue, reduced activity, reduced motivation, and mental fatigue.

    after the end of the treatment (after 8 weeks)

  • Anxiety by The State Anxiety Inventory (SAI)

    SAI is a valid and commonly used measure for anxiety The SAI includes 20 items; each item is scored on a 4-point Likert scale The SAI range of total scores is between 20 and 80, with the higher score indicating more anxiety

    at baseline

  • Anxiety by The State Anxiety Inventory (SAI)

    SAI is a valid and commonly used measure for anxiety The SAI includes 20 items; each item is scored on a 4-point Likert scale The SAI range of total scores is between 20 and 80, with the higher score indicating more anxiety

    after the end of the treatment (after 8 weeks)

  • Pain using Numerical Rating Scale (NRS)

    this scale is valid and reliable measure of pain intensity. the patient is asked to rate pain intensity be choosing a number from 0 to 10 where 0 indicates no pain and 10 indicates the worst pain ever

    at baseline

  • Pain using Numerical Rating Scale (NRS)

    this scale is valid and reliable measure of pain intensity. the patient is asked to rate pain intensity be choosing a number from 0 to 10 where 0 indicates no pain and 10 indicates the worst pain ever

    after the end of the treatment (after 8 weeks)

Study Arms (2)

virtual reality

EXPERIMENTAL

The patients in this group are under exercise training and pneumatic pressure followed by Pablo©Handle training for 45 minutes per week for 8 week -Pablo©Handle training One-dimensional therapy games using five games are available for Pablo©Handle which are (Recycle, Firefighters, Shooting Cans, Balloon, and Apple hunter) The session will be 3 min for each game about 15 min for each session 3 times per week for 8 week

Other: exercises using virtual reality technology

regular exercises

ACTIVE COMPARATOR

The patients in this group will receive exercise training and pneumatic pressure only for 30 min3 times per week for 8 week * Exercise training will be done by the following exercise for 15 min3 times per week for 8 week * Intermittent Compression Therapy Parameters: using the (Care Pump expert 8) * Pressure. 60 mmHg, Direction. Distal to proximal, Speed 4 to 5, for 15 min /3 times per week for 8 week

Other: exercises using virtual reality technology

Interventions

this is a one-dimensional therapy game using (Handle/ or Multiball) five games are available for the Pablo©Handle which are (Recycle, Firefighters, Shooting Cans, Balloon, and Applehunter) The session will be 3 min for each game about 15 min for each session 3 times per week for 8 week

Also known as: Pablo©Handle training
regular exercisesvirtual reality

Eligibility Criteria

Age40 Years - 70 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsdue to the nature of the study population (breast cancer). only females who suffered breast cancer and underwent surgical treatment will be included
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Breast cancer female patients
  • Age ≥40 years
  • All patients with Eastern Cooperative Oncology Group performance status score ≤ 2
  • Having to undergo primary treatment with surgery, chemotherapy, and/or radiotherapy based on the patient's need

You may not qualify if:

  • Severe anemia (Hb ≤ 8 g/dL)
  • Uncontrolled hypertension, diabetes
  • severe infection, neurologic or muscular diseases prohibiting physical activity
  • severe heart disease or myocardial infarction during the last six months, and a severe chronic obstructive pulmonary disease
  • uncontrolled and/or extensive brain metastases, or bone metastases that were assessed to pose a risk of pathological fractures from exercising
  • Contraindications given by the physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hail

Hail, 3994, Saudi Arabia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Concealed allocation will be performed by a researcher who will not be involved in the treatment of assessment. Permuted blocks will be used to ensure an equal 1:1 allocation ratio. Due to the nature of the study, the assessor and the data analyzer will be blindfolded (double-blinded)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: a randomized controlled trial with 2 arms parallel design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

September 21, 2023

First Posted

September 28, 2023

Study Start

September 15, 2023

Primary Completion

June 12, 2024

Study Completion

July 30, 2024

Last Updated

January 7, 2025

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations